ZFIN ID: ZDB-PUB-180310-13
C9orf72 is essential for neurodevelopment and motility mediated by cyclin G1
Yeh, T.H., Liu, H.F., Li, Y.W., Lu, C.S., Shih, H.Y., Chiu, C.C., Lin, S.J., Huang, Y.C., Cheng, Y.C.
Date: 2018
Source: Experimental neurology   304: 114-124 (Journal)
Registered Authors:
Keywords: C9orf72, Cyclin G1, Motility, Neurodevelopment, Tp53
MeSH Terms:
  • Animals
  • Apoptosis/physiology
  • C9orf72 Protein/metabolism*
  • Cyclin G1/metabolism*
  • Motor Activity/physiology*
  • Neurogenesis/physiology*
  • Zebrafish
PubMed: 29522758 Full text @ Exp. Neurol.
Hexanucleotide repeat expansions in the C9orf72 gene are a common genetic cause of familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the function of C9orf72 in neural development and the pathogenic mechanism underlying neurodegeneration are unknown. We found that disrupting C9orf72 expression by using C9orf72 constructs that lack the complete DENN domain result in reduced GTPase activity in zebrafish embryos, demonstrating the indispensability of the complete DENN domain. This effect was phenocopied by knocking down endogenous C9orf72 expression by using morpholinos. C9orf72-deficient zebrafish embryos exhibited impaired axonogenesis and motility defects. The C9orf72 deficiency upregulated the expression of tp53 and caused neuronal apoptosis. Knockdown Tp53 in the C9orf72-deficient embryos rescued only the apoptotic phenotype but not the phenotype with axonal and motility defects. The C9orf72 deficiency also induced ccng1 (encodes Cyclin G1) mRNA expression, and injection of a dominant-negative Cyclin G1 construct rescued the axonal impairment, apoptosis, and motility defects in the C9orf72-deficient embryos. Our results revealed the GTPase activity of C9orf72 and demonstrated that Cyclin G1 is an essential downstream mediator for C9orf72 in neural development and motility. Furthermore, downregulating Cyclin G1 was sufficient to rescue all the defects caused by C9orf72 deficiency. In summary, we revealed a novel regulatory mechanism underlying the role of C9orf72 in neurological and motility defects. This result facilitates understanding the function of the C9orf72 gene in the developing nervous system and provides a potential mechanism underlying the pathogenesis of ALS-FTD.